Indication
Relapsed/Refractory High-Grade B-Cell Lymphoma
1 clinical trial
1 product
Clinical trial
A Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Subjects With Relapsed/Refractory Large B-cell Lymphoma.Status:
Product
Axicabtagene Ciloleucel